AI Model Predicts B Cell Reactivity for Better Cancer Vaccines

Here’s a breakdown of the information ⁤extracted ⁢from the provided HTML snippet:

1. Journal/Publication Links:

* ⁤ Science Advances: <a class="icon_open" href="http://advances.sciencemag.org/" target="_blank" rel="nofollow">...</a>

* Nature Reviews Cancer: <a href="https://medicalxpress.com/journals/nature-reviews-cancer/"><cite>Nature Reviews Cancer</cite></a>

* Nature⁤ Reviews Cancer⁤ (direct link): <a class="icon_open" href="http://www.nature.com/nrc/index.html" target="_blank" rel="nofollow">...</a>

2. Source of the Provided Information:

* ⁤ The Korea Advanced Institute ⁤of Science and Technology (KAIST): <a href="https://medicalxpress.com/partners/the-korea-advanced-institute-of-science-and-technology--kaist/">The Korea Advanced Institute of Science and Technology (KAIST)</a>

* ‍ KAIST Website: <a class="icon_open" href="http://www.kaist.edu/" target="_blank" rel="nofollow">...</a>

3.Citation Information (Print Only):

* Title: AI model ⁢predicts B cell reactivity to neoantigens for‍ improved cancer vaccines
* Year: ⁣ 2026
* date: January 2

this snippet indicates that‍ a news ‍article or press release about an AI model for cancer vaccines originates‍ from KAIST and is related to research perhaps published in Science Advances and Nature Reviews Cancer. The citation information is provided for print purposes.